home / stock / tlsa / tlsa news


TLSA News and Press, Tiziana Life Sciences plc From 06/13/25

Stock Information

Company Name: Tiziana Life Sciences plc
Stock Symbol: TLSA
Market: NASDAQ
Website: tizianalifesciences.com

Menu

TLSA TLSA Quote TLSA Short TLSA News TLSA Articles TLSA Message Board
Get TLSA Alerts

News, Short Squeeze, Breakout and More Instantly...

TLSA - Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human...

TLSA - Tiziana shares rise on presentation date for foralumab data

2025-06-13 09:36:11 ET More on Tiziana Life Sciences Tiziana posts favorable PET scan data for lead asset in Alzheimer's Tiziana rises on positive results in multiple sclerosis treatment study Financial information for Tiziana Life Sciences Read the full ar...

TLSA - Tiziana Life Sciences to Present at the Bio International Convention

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human...

TLSA - Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human,...

TLSA - SA Market Talk: Musk says he'll head Tesla for at least 5 years

2025-05-20 10:49:50 ET More on Tesla, Home Depot, etc. Tesla's Future: Robotaxi Dreams Meet Overbought Signals Tesla: An Energy Giant In The Making Tesla's Hot Streak Faces Reality Check: Can The Rally Hold? Elon Musk sees still being CEO of Tesla in five yea...

TLSA - Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human,...

TLSA - Tiziana Life Sciences reports purchase of shares by chairman

2025-05-12 08:04:49 ET More on Tiziana Life Sciences Tiziana: Foralumab Drug Development Presses On With Additional EAP Enrollment Tiziana posts favorable PET scan data for lead asset in Alzheimer's Tiziana rises on positive results in multiple sclerosis treatment st...

TLSA - Tiziana Life Sciences Announces Purchase of Shares by Chairman

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human a...

TLSA - Tiziana posts favorable PET scan data for lead asset in Alzheimer's

2025-05-09 07:33:51 ET More on Tiziana Life Sciences Tiziana: Foralumab Drug Development Presses On With Additional EAP Enrollment Tiziana rises on positive results in multiple sclerosis treatment study Tiziana Life Sciences ticks up on IND submission for mid-stage t...

TLSA - Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human ...

Previous 10 Next 10